BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2004
View Archived Issues
Methylphenidate enhances the beneficial effects of levodopa in Parkinson's disease
Read More
Adiponectin reduces body weight in mice by increasing metabolic rate without reducing food intake
Read More
Intravitreal pegaptanib reported safe and effective in ocular neovascularization disorders
Read More
Ono scientists describe new chemokine CCR5 antagonists and their therapeutic use
Read More
New immunosuppressant agents covered by Kyorin patent
Read More
Dual D2/5-HT2A antagonists for use in schizophrenia claimed by Pfizer
Read More
Schering-Plough and Pharmacopeia present novel CDK inhibitors
Read More
New inhibitors of cytokine release under study at Procter & Gamble
Read More
Salsalate shows promise as a novel drug for type 2 diabetes
Read More
Vitrase approved by FDA as spreading agent; phase III results in vitreous hemorrhage also presented
Read More
Novel cannabinoid CB1 ligands prepared and tested at Solvay
Read More
Inhaled insulin reported more effective than other therapies for type 2 diabetes
Read More
Two series of chemokine CCR5 antagonists and their use in HIV infection
Read More
Good safety profile of mycophenolate mofetil in multiple sclerosis
Read More
Newron and Zambon on pain treatment development
Read More
Phase II trial under way for TNX-355 for HIV
Read More
Aurograb enters phase III
Read More
Regulatory clearances for Cerepro study
Read More
Tectin enters pivotal trial in cancer-related pain
Read More
Samaritan advances HIV pipeline
Read More
PD-6735 successfully completes phase I trial, enters phase II
Read More
Anthim selected for testing by CDC
Read More
Imvamune IND receives approval
Read More
BioLineRx licenses neurological platform from Tel Aviv, Bar Ilan Universities
Read More
Pivotal BioSciences and ProteomTech collaborate on development of PB1
Read More
Completion of ReceptoPharm's HIV in vitro studies
Read More
Positive opinion for Humira label extension in E.U.
Read More
Ilex Oncology focuses on key compounds during first quarter
Read More
Celgene increases R&D investment in Q1 2004
Read More
Merck & Co. highlights first quarter developments
Read More
Further data on use of darifenacin for treatment of overactive bladder
Read More
AUA news: First clinical results with stem cell therapy in urinary incontinence presented
Read More